[Cardiorenal syndrome].
With increasing age of a population, the rate and severity of comorbidities are also growing, resulting in a rising number of people with a condition described as "cardiorenal syndrome". Initially, cardiorenal syndrome defined the decline in cardiac and renal function due to diminished renal perfusion in the context of heart failure. However, in order to give consideration to the numerous comorbidities, nowadays the definition has been widened. Following a new classification, five types of cardiorenal syndrome are distinguished. Such a differentiation is helpful to find the appropriate therapeutic approach, according to the underlying disease. Therefore, the new classification and modern therapeutic concepts shall be presented here.
Galle
Jan
J
Klinik für Nephrologie und Dialyseverfahren, Klinikum Lüdenscheid, Lüdenscheid. J.Galle@klinikum-luedenscheid.de
D003131:Combined Modality Therapy; D015897:Comorbidity; D003430:Cross-Sectional Studies; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000145:classification / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007511:Ischemia / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply; D007676:Kidney Failure, Chronic / Q000145:classification / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D007677:Kidney Function Tests; D006435:Renal Dialysis; D012084:Renin-Angiotensin System / Q000502:physiology; D012307:Risk Factors; D013564:Sympathetic Nervous System / Q000503:physiopathology; D013577:Syndrome; D014882:Water-Electrolyte Balance / Q000502:physiology
D004232:Diuretics